Tecan Group AGLTS:0QLN -0.63%73 PB Ratio is 1.94 as of Jul. 06, 2026, which is 53% below its 10-year median of 4.09. GuruFocus rates LTS:0QLN with a GF Score™ of 73/100 and a GF Value™ of CHF244.11 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Tecan Group AG ranks better than 53.43% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-06), Tecan Group AG's share price is CHF176.73078. Tecan Group AG's Book Value per Share for the quarter that ended in Dec. 2025 was CHF90.98. Hence, Tecan Group AG's PB Ratio of today is 1.94.
Warning Sign:
Tecan Group AG stock PB Ratio (=1.94) is close to 1-year high of 1.94.
The historical rank and industry rank for Tecan Group AG's PB Ratio or its related term are showing as below:
LTS:0QLN'
s PB Ratio Range Over the Past 10 Years
Min: 1.12 Med: 4.09 Max: 9.63
Current: 1.94
During the past 13 years, Tecan Group AG's highest PB Ratio was 9.63. The lowest was 1.12. And the median was 4.09.
LTS:0QLN's PB Ratio is ranked better than 53.43% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs LTS:0QLN: 1.94
During the past 12 months, Tecan Group AG's average Book Value Per Share Growth Rate was -19.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -5.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 7.20% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 12.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Tecan Group AG was 30.40% per year. The lowest was -5.20% per year. And the median was 11.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Tecan Group AG PB Ratio Related Terms
Tecan Group AG PB Ratio Historical Data
* Premium members only.
The historical data trend for Tecan Group AG's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Tecan Group AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tecan Group AG PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tecan Group AG's PB Ratio distribution charts can be found below:
* The bar in red indicates where Tecan Group AG's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Tecan Group AG's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Tecan Group AG (LTS:0QLN) has a PB Ratio of 1.94 as of Jul. 06, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Tecan Group AG and its competitors. This is 53% below median its historical median of 4.09. Over the past decade, Tecan Group AG's PB Ratio has ranged from 1.12 to 9.63. According to the industry distribution chart, Tecan Group AG ranks #367 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 46.6%.
Is Tecan Group AG's PB Ratio too high?
Tecan Group AG's current PB Ratio of 1.94 is 53% below median its 10-year median of 4.09. Over the past 10 years, this metric has ranged from a low of 1.12 to a high of 9.63. The Medical Devices & Instruments industry median PB Ratio is 2.07. Tecan Group AG's value of 1.94 is 6.3% below this industry median. Based on the distribution chart, Tecan Group AG ranks #367 out of 788 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Tecan Group AG has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tecan Group AG's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Tecan Group AG ranks #367 out of 788 companies for PB Ratio. This puts Tecan Group AG in the upper half of its industry. The industry median PB Ratio is 2.07. Tecan Group AG's value of 1.94 is 6.3% below this benchmark. Historically, Tecan Group AG's own PB Ratio has ranged from 1.12 to 9.63 over the past decade. While the company's 10-year median is 4.09 vs. the industry median of 2.07, Tecan Group AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.07, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tecan Group AG's current PB Ratio of 1.94 is 6.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Tecan Group AG and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tecan Group AG's current PB Ratio is 1.94, which is 53% below median its own 10-year median of 4.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tecan Group AG stock overvalued right now?
Based on GuruFocus' analysis, Tecan Group AG (LTS:0QLN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF244.11, compared to a current price of CHF176.73 — trading 27.6% below its estimated fair value. The current PB Ratio is 1.94, which is 53% below median its 10-year median of 4.09 and 6.3% below the Medical Devices & Instruments industry median of 2.07. Tecan Group AG's overall GF Score™ is 73/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Tecan Group AG (LTS:0QLN), the current PB Ratio is 1.94 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tecan Group AG (LTS:0QLN) Overvalued in 2026?
Based on GuruFocus' analysis, Tecan Group AG stock appears to be undervalued.
The current stock price of CHF176.73 is trading 27.6% below its estimated GF Value™ of CHF244.11.
GuruFocus considers Tecan Group AG to be Modestly Undervalued.
Key valuation signals for LTS:0QLN:
PB Ratio: 1.94 (53% below median its 10-year median of 4.09)
GF Value™: CHF244.11 vs. price of CHF176.73 (27.6% below fair value)
Industry Position: 6.3% below the Medical Devices & Instruments median (#367 of 788)
No single metric tells the full story. See the LTS:0QLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; The Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, The partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their names. A majority proportion of Tecan's revenue is generated in the Americas and Europe followed by Asia Specific.
73GF Score
Get the complete analysis for LTS:0QLN
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QLN has been successfully added to your 
